Esophageal Diagnostic System Reaches New Milestone
A diagnostic system provides rapid physiologic assessment during endoscopy to help clarify persistent esophageal symptoms.
Updated on Oct. 29, 2026 in Allergies
Live Poll
Would you seek out specialized point-of-care diagnostic testing for persistent gastrointestinal symptoms?
The MiVu Mucosal Integrity Testing System has now been used in more than 25,000 clinical procedures worldwide to assess esophageal health. This diagnostic tool provides rapid physiologic measurements during an upper endoscopy to help clinicians differentiate between various esophageal conditions.
Why it matters
Accurate differentiation between conditions like GERD and eosinophilic esophagitis is critical for effective patient management. By providing objective data on mucosal integrity, this system offers a standardized approach to esophageal assessment that can help guide targeted treatment decisions.
Clinical data supporting the MiVu system includes a reported 100% sensitivity for eosinophilic esophagitis and 95% specificity for GERD. While these metrics indicate high diagnostic performance, the system’s long-term impact on overall patient outcomes remains under investigation.
The players
Diversatek
A medical technology company that develops the MiVu Mucosal Integrity Testing System for gastrointestinal assessment.
The details
The MiVu system uses a disposable Endo Cap attached to a standard endoscope to measure mucosal impedance, which is a physical property of the esophageal lining. By analyzing this impedance, the system generates color-coded patterns that allow clinicians to differentiate between GERD, eosinophilic esophagitis, and non-GERD states. The physiologic assessment is completed in less than two minutes during an upper endoscopy.
Timeline
October 29, 2026: Diversatek announced the 25,000 procedure milestone.
Health Landscape
The use of the MiVu Mucosal Integrity Testing System marks a shift from traditional visual inspection of the esophagus to a standardized, quantitative physiologic assessment. This transition reflects a broader trend toward integrating objective diagnostic markers into routine endoscopy procedures.
If you are undergoing an endoscopy for unexplained esophageal symptoms, you may want to ask your gastroenterologist if objective mucosal integrity testing is available. Discussing these diagnostic options with your doctor can help clarify whether your results require specific treatment protocols for GERD or allergic conditions.
The takeaway
Rapid, objective testing of esophageal mucosa helps distinguish between common conditions that often present with similar symptoms. If you struggle with persistent throat or digestive discomfort, ask your physician about available diagnostic tools that go beyond standard visual examinations.
Further reading
For more on managing symptoms, see our guide on Allergies.
Source note: This article includes information reported by Haiti Sun.
Live Poll
Would you seek out specialized point-of-care diagnostic testing for persistent gastrointestinal symptoms?
